[Federal Register: June 3, 2003 (Volume 68, Number 106)]
[Notices]
[Page 33149-33150]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03jn03-81]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-03-71]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 498-1210. CDC is requesting an emergency
clearance for this data collection with a two week public comment
period. CDC is requesting OMB approval of this package 7 days after the
end of the public comment period.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Send comments to Anne O'Connor, CDC
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24,
Atlanta, GA 30333. Written comments should be received within 14 days
of this notice.
Proposed Project: Project DIRECT: Phase 2, Evaluation of Impact of
Multilevel Community Interventions--New--National Center for Chronic
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease
Control and Prevention (CDC). Project DIRECT (Diabetes Intervention
Reaching and Educating Communities Together) is the first comprehensive
[[Page 33150]]
community based project in the United States to address the growing
burden of diabetes in African Americans. The goal of the project is to
use existing knowledge of diabetes risk factors and complications to
implement community level interventions to reduce the prevalence and
severity of diabetes in communities with large African American
populations. A community in Raleigh, North Carolina was selected as the
demonstration site for the project. An area in Greensboro, NC, was
identified as a suitable comparison community. The Division of Diabetes
Translation (DDT) at the Centers for Disease Control and Prevention
(CDC) is collaborating with the state of North Carolina to implement
and evaluate public health strategies for reducing the burden of
diabetes in this predominately African American community.
Project DIRECT has three distinct intervention components--Health
Promotion, Outreach, and Diabetes Care. The goals of all three
interventions are to reduce or prevent diabetes and its complications,
but each has a different but complimentary approach.
Project DIRECT implemented a baseline population-based survey in
1996-1997. Interventions have been employed since then and continue to
the present. A follow-up study is now required to evaluate the impact
of this multilevel approach to diabetes prevention and control. Data
from this project will be critical to the Division of Diabetes
Translation's on-going efforts to reduce the burden of diabetes, and to
determine whether a similar program could be implemented successfully
in other communities. A pre-post design was selected for the evaluation
to determine if any changes observed for these outcomes might be
attributed to the interventions used in Project DIRECT by comparing
changes in the intervention and comparison communities. The baseline
study for the pre-post evaluation was conducted during 1996-1997.
Households in Raleigh and Greensboro communities would be selected at
random using mailing lists. An interviewer will verify the address and
do an initial screening for eligible participants in the household.
Eligible participants will be asked to participate in the study and
will have to complete a consent form. All participants will be asked to
complete an interview on their health status and lifestyle and measured
for height and weight. Participants who self-report a history of
diabetes will be asked additional questions (diabetes module) about
their management of diabetes and its complications and other related
health conditions.
All participants who self-report a history of diabetes and a sub-
sample of those without diabetes would be invited to participate in a
household examination that will include blood pressure and waist
circumference measurement and a blood draw for laboratory analysis
including blood glucose and lipids concentrations. For quality control
purposes, a small sample of participants will be asked to do a short
telephone interview to verify information collected during the general
interview.
The only cost to respondents is their time to participate in the
study.
----------------------------------------------------------------------------------------------------------------
Average burden
Form Number of Responses per per response Total burden
respondents respondent (hours) (hours)
----------------------------------------------------------------------------------------------------------------
Screening Questionnaire......................... 4,600 1 5/60 383
General Population Questionnaire................ 2,603 1 30/60 1,302
Diabetes Module................................. 565 1 30/60 283
Verification Questionnaire...................... 1,535 1 30/60 768
-----------------
Total....................................... 4,600 .............. .............. 2,736
----------------------------------------------------------------------------------------------------------------
Dated: May 28, 2003.
Thomas A. Bartenfeld,
Acting Director, Office of Program Planning and Evaluation, Centers for
Disease Control Prevention.
[FR Doc. 03-13786 Filed 6-2-03; 8:45 am]
BILLING CODE 4163-18-P